K. Sjögreen Gleisner

发表

3-D Image-Based Dosimetry in Radionuclide Therapy

M. Ljungberg, K. Sjögreen Gleisner, K. S. Gleisner, 2018, IEEE Transactions on Radiation and Plasma Medical Sciences.

SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy

K. Sjögreen Gleisner, J. Gustafsson, A. Sundlöv, 2017, EJNMMI Research.

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools

M. Ljungberg, K. Sjögreen Gleisner, 2016, Biomedicines.

Characterisation of a hand-held CZT-based gamma camera for 177Lu imaging

K. Sjögreen Gleisner, A. Sundlöv, E. Larsson, 2020, EJNMMI Physics.

Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively.

K. Sjögreen Gleisner, J. Genollá, P. Mínguez, 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer.

G. Flux, K. Sjögreen Gleisner, J. Genollá, 2016, Medical physics.

Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

G. Flux, K. Sjögreen Gleisner, J. Genollá, 2015, Medical physics.

Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy

M. Ljungberg, P. Bernhardt, K. Sjögreen Gleisner, 2018, EJNMMI Physics.

Long-Term Retention of 177Lu/177mLu-DOTATATE in Patients Investigated by γ-Spectrometry and γ-Camera Imaging

K. Sjögreen Gleisner, Gustav Brolin, A. Sundlöv, 2015, The Journal of Nuclear Medicine.

Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy

M. Ljungberg, K. Sjögreen Gleisner, 2015, Diagnostics.

Monte Carlo modelling of a compact CZT-based gamma camera with application to 177Lu imaging

M. Ljungberg, K. Sjögreen Gleisner, E. Larsson, 2022, EJNMMI Physics.

Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey

E. Spezi, C. Stokke, M. Sandström, 2017, EJNMMI Physics.

Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy

T. Ohlsson, C. Hindorf, K. Sjögreen Gleisner, 2022, EJNMMI research.

A method for tumor dosimetry based on hybrid planar‐SPECT/CT images and semiautomatic segmentation

Johan Gustafsson, Daniel Roth, Anna Sundlöv, 2018, Medical physics.

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands

C. Stokke, M. Cremonesi, F. Verburg, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Evaluation of quantitative 90Y SPECT based on experimental phantom studies

M Ljungberg, M. Ljungberg, D. Minařík, 2008, Physics in medicine and biology.

Consequences of inadvertent radioiodine treatment of Graves’ disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?

L. Jacobsson, E. Nyström, K. Sjögreen Gleisner, 2008, Acta oncologica.

Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer.

G. Flux, K. Sjögreen Gleisner, J. Genollá, 2016, Medical Physics (Lancaster).

Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE

K. Sjögreen Gleisner, A. Sundlöv, J. Tennvall, 2021, The Journal of Nuclear Medicine.

Averaging of absorbed doses: How matter matters.

M. Ljungberg, G. Alm Carlsson, K. Sjögreen Gleisner, 2023, Medical Physics (Lancaster).

The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise.

L. Indovina, S. Gnesin, A. Sarnelli, 2023, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification

K. Sjögreen Gleisner, J. Gustafsson, Erik Larsson, 2024, EJNMMI physics.

Retrospective evaluation of the predictive value of tumour burden at baseline [68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT

E. Trägårdh, K. Sjögreen Gleisner, A. Sundlöv, 2024, EJNMMI reports.

On the use of solid 133Ba sources as surrogate for liquid 131I in SPECT/CT calibration: a European multi-centre evaluation

J. Tran-Gia, F. Fioroni, K. Sjögreen Gleisner, 2023, EJNMMI Physics.

Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE

E. Wieslander, K. Sjögreen Gleisner, J. Svensson, 2024, The Journal of Nuclear Medicine.

Feasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera

K. Sjögreen Gleisner, D. Roth, Erik Larsson, 2024, EJNMMI physics.